Studies performed in vitro, as well as evidence from numerous in situ examinations, indicate that tumour-expressed FasL is associated with apoptosis of TIL and may thus protect tumour cells from destruction by the immune system (O’Connell et al, 2001; Whiteside, 2007). This evidence concerns the gene FASLG and neoplasm.